TY - JOUR
T1 - Pituitary volume, stress reactivity and genetic risk for psychotic disorder
AU - Habets, P.
AU - Collip, D.
AU - Myin-Germeys, I.
AU - Gronenschild, E.
AU - Van Bronswijk, S.
AU - Hofman, P.
AU - Lataster, T.
AU - Lardinois, M.
AU - Nicolson, N. A.
AU - Van Os, J.
AU - Marcelis, M.
PY - 2012/7
Y1 - 2012/7
N2 - Background Hypothalamic-pituitary-adrenal (HPA) axis hyperactivity, associated with increased pituitary volume, may mediate observed alterations in stress reactivity in patients with psychotic disorder. We examined the association between pituitary volume, real-life stress reactivity and genetic liability for psychotic disorder.Method Pituitary volumes were derived from magnetic resonance imaging (MRI) scans of 20 patients with psychotic disorder, 37 non-psychotic siblings of these patients, and 32 controls. The Experience Sampling Method (ESM) was used to measure emotional stress reactivity [changes in negative affect (NA) associated with daily life stress] in the three groups, and biological stress reactivity (changes in cortisol associated with daily life stress) in siblings and controls. Interactions between group, stress and pituitary volume in models of NA and cortisol were examined.Results Groups did not differ in pituitary volume. Patients showed significantly higher emotional stress reactivity than siblings and controls. In addition, emotional stress reactivity increased with increasing pituitary volume to a greater degree in patients than in controls and siblings. Siblings had higher cortisol levels than controls but did not show increased cortisol reactivity to stress. There was no interaction between pituitary volume, stress and group in the model of cortisol.Conclusions Higher pituitary volume was associated with increased emotional stress reactivity in patients with psychotic disorder, siblings and controls. The association was significantly stronger in the patient group, suggesting a process of progressive sensitization mediating clinical outcome.
AB - Background Hypothalamic-pituitary-adrenal (HPA) axis hyperactivity, associated with increased pituitary volume, may mediate observed alterations in stress reactivity in patients with psychotic disorder. We examined the association between pituitary volume, real-life stress reactivity and genetic liability for psychotic disorder.Method Pituitary volumes were derived from magnetic resonance imaging (MRI) scans of 20 patients with psychotic disorder, 37 non-psychotic siblings of these patients, and 32 controls. The Experience Sampling Method (ESM) was used to measure emotional stress reactivity [changes in negative affect (NA) associated with daily life stress] in the three groups, and biological stress reactivity (changes in cortisol associated with daily life stress) in siblings and controls. Interactions between group, stress and pituitary volume in models of NA and cortisol were examined.Results Groups did not differ in pituitary volume. Patients showed significantly higher emotional stress reactivity than siblings and controls. In addition, emotional stress reactivity increased with increasing pituitary volume to a greater degree in patients than in controls and siblings. Siblings had higher cortisol levels than controls but did not show increased cortisol reactivity to stress. There was no interaction between pituitary volume, stress and group in the model of cortisol.Conclusions Higher pituitary volume was associated with increased emotional stress reactivity in patients with psychotic disorder, siblings and controls. The association was significantly stronger in the patient group, suggesting a process of progressive sensitization mediating clinical outcome.
KW - Genetic predisposition to disease
KW - hypothalamo-hypophyseal system
KW - magnetic resonance imaging
KW - pituitary gland
KW - pituitary-adrenal system
KW - psychological stress
KW - schizophrenia
KW - stress
UR - http://www.scopus.com/inward/record.url?scp=84861444284&partnerID=8YFLogxK
U2 - 10.1017/S0033291711002728
DO - 10.1017/S0033291711002728
M3 - Article
C2 - 22130309
AN - SCOPUS:84861444284
SN - 0033-2917
VL - 42
SP - 1523
EP - 1533
JO - Psychological Medicine
JF - Psychological Medicine
IS - 7
ER -